The EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture.
Hamburg-headquartered Evotec SE has extended and expanded its three-year-old partnership with Bristol Myers Squibb in targeted protein degradation ("molecular glue degraders") for an additional eight years.
Bristol Myers Squibb brings in a huge library of E3 ligase modulators. Under the terms of the agreement, both parties will leverage all of Evotecs appropriate platforms as well as AI/ML-based drug discovery.
Under the new agreement, Evotec cashes in an upfront payment of $200m and is eglible to obtain up to $5bn in milestone payments and tiered royalties on product sales.
Replacing 20% of global beef consumption with fermentation-derived microbial protein by 2050 could halve annual deforestation and associated carbon dioxide emissions.
Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.
Cancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics.
The Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel.
Digital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space.
Swiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice.
Industrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon.
If our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers.